Source link : https://www.newshealth.biz/health-news/sglt2-inhibitors-tied-to-better-outcomes-in-pulmonary-arterial-hypertension/
BOSTON — Sodium-glucose cotransporter-2 (SGLT2) inhibitors were linked to long-term reductions in mortality risk among patients with pulmonary arterial hypertension (PAH), according to an observational cohort study. At 1 year follow-up, 8.1% of patients with PAH who were prescribed SGLT2 inhibitors had died, compared with 15.5% of patients who did not take SGLT2 inhibitors (7.4% […]
Author : News Health
Publish date : 2024-10-07 16:05:29
Copyright for syndicated content belongs to the linked Source.